Best Practice Advocacy Centre New Zealand

CPD information

Prescribing Reports

Audits

CME Quizzes

Peer Group Discussions

My Bpac account

Adverse drug reactions and interactionsAllergies and immunologyAntibiotic resistance and stewardshipBiochemistryCancer careCardiovascular systemChild healthComplementary and alternative medicinesCorrespondenceDebatesDermatologyDiabetesEar, nose and throatEndocrinology (excl diabetes)Feature lettersGastroenterologyGeneticsGenitourinary system (male)GuidelinesGynaecology and urinary tract disorders (female)HaematologyHealth informaticsHepatologyImmunisationInfectionsIntegrated Performance and Incentive FrameworkMāori healthMedicine indicationsMedicine subsidyMedicines managementMedico-legal issuesMental healthMusculoskeletalNephrologyNeurologyNewsNutritionOccupational medicineOlder person’s healthOncologyOphthalmologyOral healthPacific peoples healthPain managementPalliative carePeer group discussionsPharmacologyPHO Performance ProgrammePregnancy and reproductive healthProfessional practice and developmentPublic healthReportsResearch updatesRespiratory conditionsRheumatologySexual healthSmoking, alcohol, and drug misuseTrauma and surgical proceduresVirology

Search from:

Back to:

Jump to year:

202120202019201820172016

Medicine subsidy

Choose another category

Adverse drug reactions and interactionsAllergies and immunologyAntibiotic resistance and stewardshipBiochemistryCancer careCardiovascular systemChild healthComplementary and alternative medicinesCorrespondenceDebatesDermatologyDiabetesEar, nose and throatEndocrinology (excl diabetes)Feature lettersGastroenterologyGeneticsGenitourinary system (male)GuidelinesGynaecology and urinary tract disorders (female)HaematologyHealth informaticsHepatologyImmunisationInfectionsIntegrated Performance and Incentive FrameworkMāori healthMedicine indicationsMedicine subsidyMedicines managementMedico-legal issuesMental healthMusculoskeletalNephrologyNeurologyNewsNutritionOccupational medicineOlder person’s healthOncologyOphthalmologyOral healthPacific peoples healthPain managementPalliative carePeer group discussionsPharmacologyPHO Performance ProgrammePregnancy and reproductive healthProfessional practice and developmentPublic healthReportsResearch updatesRespiratory conditionsRheumatologySexual healthSmoking, alcohol, and drug misuseTrauma and surgical proceduresVirology

2021

New diabetes medicines funded: empagliflozin and dulaglutide

July 2021

Prescribing ACE inhibitors: time to reconsider old habits

March 2021

2020

News Update: cilazapril with hydrochlorothiazide will no longer be available in New Zealand

March 2020

Biosimilars: the future of prescribing biological medicines

January 2020

2019

News update: Criteria widened for exceptional circumstances funding of lamotrigine

November 2019

The funded brand of lamotrigine is changing

August 2019

Antiarrhythmic medicine brand changes: flecainide and amiodarone

July 2019

2018

Vildagliptin: a new treatment for type 2 diabetes

September 2018

Aripiprazole prescribing changes: Special Authority approval no longer required, new sole-subsidised brand

June 2018

Prescribing gabapentin and pregabalin: upcoming subsidy changes

March 2018

Methylnaltrexone is a subsidised treatment option for opioid-induced constipation in palliative care

January 2018

2017

Intravenous ferric carboxymaltose: now available for the treatment of iron deficiency

November 2017

4% dimethicone lotion: a subsidised treatment for head lice

May 2017

2016

Access to HPV vaccine widened

November 2016

Made with by the bpac^nz team

Partner links